Ufp Technologies (UFPT) Net Cash Flow (QoQ) (2010 - 2026)
Ufp Technologies (UFPT) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10,433.98% |
| Mar 31, 2026 | -104.91% |
| Dec 31, 2025 | -33.58% |
| Sep 30, 2025 | 428.43% |
| Jun 30, 2025 | 102.71% |
| Mar 31, 2025 | 113.55% |
| Dec 31, 2024 | -273.41% |
| Sep 30, 2024 | -110.84% |
| Jun 30, 2024 | -13.34% |
| Mar 31, 2024 | 577.68% |
| Dec 31, 2023 | -205.35% |
| Sep 30, 2023 | 200.33% |
| Jun 30, 2023 | -158.05% |
| Mar 31, 2023 | 136.51% |
| Dec 31, 2022 | -230.87% |
| Sep 30, 2022 | 119.90% |
| Jun 30, 2022 | 126.85% |
| Mar 31, 2022 | 65.85% |
| Dec 31, 2021 | -879.05% |
| Sep 30, 2021 | -42.38% |